Uribesalgo, Iris <br/><br/>
Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.  [electronic resource] 

 -  EMBO molecular medicine  08 2019 
 - e9266 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1757-4684 
<br/><br/><label>Standard No.: </label>10.15252/emmm.201809266  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Apelin--antagonists & inhibitors<br/>Apelin Receptors--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Drug Resistance, Neoplasm<br/>Endothelial Cells--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mammary Neoplasms, Experimental--drug therapy<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mouse Embryonic Stem Cells--drug effects<br/>Neoplasm Metastasis<br/>Neovascularization, Pathologic<br/>Protein Kinase Inhibitors--pharmacology<br/>Signal Transduction<br/>Sunitinib--pharmacology<br/>Tumor Burden--drug effects<br/>Tumor Microenvironment